Recombinant subunit vaccine with adjuvant

This page covers all Recombinant subunit vaccine with adjuvant drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Varicella-zoster virus glycoprotein E (gE).

Targets

Varicella-zoster virus glycoprotein E (gE)

Marketed (2)

• recombinant adjuvanted zoster vaccine · Wuerzburg University Hospital · Immunology / Infectious Disease
  This vaccine stimulates the immune system to recognize and respond to varicella-zoster virus (VZV) antigens, with an adjuvant component enhancing the immune response.
• Zoster Vaccine Recombinant, Adjuvanted · Wuhan BravoVax Co., Ltd. · Immunology / Infectious Disease
  This recombinant zoster vaccine with adjuvant stimulates the immune system to generate protective antibodies and cell-mediated immunity against varicella-zoster virus (VZV) to prevent herpes zoster (shingles).

Phase 3 pipeline (1)

• HZ/su · GlaxoSmithKline · Immunology / Infectious Disease
  HZ/su is a recombinant zoster vaccine that stimulates immune responses against varicella-zoster virus to prevent herpes zoster (shingles) and post-herpetic neuralgia.

Patent intelligence

• recombinant subunit vaccine with adjuvant patent landscape — aggregated cliff calendar, attackable patents, originator estates